Superchain Procedures in Clinical Trials. George Kordzakhia FDA, CDER, Office of Biostatistics Alex Dmitrienko Quintiles Innovation

Size: px
Start display at page:

Download "Superchain Procedures in Clinical Trials. George Kordzakhia FDA, CDER, Office of Biostatistics Alex Dmitrienko Quintiles Innovation"

Transcription

1 August 01, 2012

2 Disclaimer: This presentation reflects the views of the author and should not be construed to represent the views or policies of the U.S. Food and Drug Administration

3 Introduction We describe a new class of multiple testing procedures for addressing multiplicity problems arising in clinical trials with multiple objectives grouped into families. The families may correspond to equally important sets of objectives, e.g., co-primary endpoints, or ordered sets of objectives, e.g., primary and secondary endpoints. The procedures, termed superchain procedures, serve as an extension of several classes of other multiple testing procedures, including chain procedures and parallel gatekeeping procedures.

4 Example 1: Two-family problem Clinical trial where experimental treatment is evaluated versus placebo at two dose levels (Dose 1, Dose 2) with respect to two endpoints (Endpoint 1, Endpoint 2). Four null hypotheses grouped into 2 families. Family Hypotheses Endpoint Comparison F 1 H 1 Endpoint 1 Dose 1 vs Placebo F 1 H 2 Endpoint 1 Dose 2 vs Placebo F 2 H 3 Endpoint 2 Dose 1 vs Placebo F 2 H 4 Endpoint 2 Dose 2 vs Placebo If two families may be treated as co-primary families, they can be tested simultaneously rather than sequentially.

5 procedure for two families Hypothesis testing problem with n null hypotheses grouped into 2 families: F 1 and F 2. The non-negative weights w 1 and w 2 with w 1 + w 2 =1 are assigned to F 1 and F 2 to quantify relative importance of the two families. At each step of the procedure, families F i, i =1, 2are tested simultaneously by component procedures P i at the α i level (to be specified). Component procedures P i, i =1,...,2, are derived using the closure principle and control the local FWER within F i.

6 procedure for two families At Step 1, families F i are tested at respective significance levels α i = w i α. Whenever one or more null hypotheses are rejected in a family, a certain fraction of FWER is released and can be transferred to other family. The transition parameters g ij 0 specify how the error rate is distributed. w 1 F 1 g 12 g 21 w 2 F 2

7 procedure for two families Truncated component procedures Assume that P i are truncated Hochberg (Holm or Hommel) procedures with truncation parameters 0 γ i 1. Truncated procedure is defined by computing a convex combination of the critical values of the original procedure with the critical values of the Bonferroni procedure based on the truncation parameter. Power of truncated procedures P i increases monotonically with the increase of γ i. Denote by γ i,0 the initial values of the truncation parameters for P i

8 procedure for two families Monotonicity (power pumping) Each null hypothesis that is rejected in F j, j i pumps the significance level for testing F i. The component procedures used in family F i, i =1, 2at each step of the algorithm, depend on the set of rejected null hypotheses in the other family denoted by R j, j i: P 1 P 1 [R 2 ], P 2 P 2 [R 1 ]. The truncation parameters γ i of P i grow monotonically as more null hypotheses are rejected in F j, j i. Thus, more powerfull tests are applied to all families at subsequent steps and the sets of testable hypotheses shrink from one step to the next.

9 Example 1 (continued) Clinical trial with four null hypotheses H 1, H 2, H 3, H 4 grouped into two families. Components are Hochberg based truncated Hochberg procedures Let 0 <γ i,0 < 1 denote the initial values of the truncation parameters for P i s Family Hypotheses Component Initial γ i F 1 H 1 H 2 Hochberg(γ 1 ) γ 1,0 =1/2 F 2 H 3 H 4 Hochberg(γ 2 ) γ 2,0 =1/2

10 Example 1 Consider case of equally weighted endpoints (Endpoints 1 and 2 are equally important): w 1 =1/2, w 2 =1/2. The families are logically related through the following graph with the transition weights g 12 and g 21 equal to F F 2

11 Example 1 Decision rules for truncated Hochberg Let ordered p-values in F 1 be p (1) < p (2). Hochberg (γ 1 ) rejects intersection hypothesis H 1 H 2 locally if p (1) < (γ 1 /2+(1 γ 1 )/2)α 1 = α 1 /2 or p (2) < (γ 1 +(1 γ 1 )/2)α 1 =(1+γ 1 )α 1 /2. Thus, within family F 1, both null hypotheses are rejected if p (2) (1 + γ 1 )α/2; only H (1) is rejected if p (1) α/2 andp (2) > (1 + γ 1 )α/2.

12 Example 1 Suppose the raw p-values for the null hypotheses are given by Hypotheses H 1 H 2 H 3 H 4 p-values The global FWER to be controlled at a one-sided α =0.025

13 Example 1 Step 1. Test F 1 by Hochberg(1/2) at level α 1 = α/2 = Since p 1 α 1 /2, and p 2 > (1 + γ 1,0 )α 1 /2=3α 1 /4, only H 1 is rejected, and, thus, R 1 = {H 1 }. Test F 2 by Hochberg(1/2) at level α 2 = α/2 = Since p 3 α 2 /2, and p 4 > (1 + γ 2,0 )α 2 /2=3α 2 /4, only H 3 is rejected. Thus, R 2 = {H 2 }.

14 Example 1 Updating significance levels, and truncation parameters ( α 1 = κ 1 α = w 1 + (1 γ ) 2,0) R 2 w 2 α = 5α n 2 8 Similarly, γ 1 = w 1 κ 1 γ 1,0 + κ 1 w 1 κ 1 1= 3 5. α 2 = 5α 8, γ 2 = 3 5.

15 Example 1 Step 2. Retest F 1 by Hochberg(3/5) at significance level α 1 =5α/8 = Since p 2 < (1 + γ 1 )α 1 /2=0.0125, both, H 1 and H 2 are rejected. Thus, R 1 = {H 1, H 2 }. Retest F 2 by Hochberg(3/5) at level α 2 =5α/8 = Since p 4 > (1 + γ 2 )α 2 /2=0.0125, no new rejections in F 2,andR 2 = {H 3 }.

16 Example 1 Step 3. Since all hypotheses in F 1 are rejected, retest F 2 by Hochberg(1) at full significance level α = p 4 < 0.025, and, thus, both hypotheses are rejected in F 2 The final set of null hypotheses rejected by the superchain procedure includes H 1, H 2, H 3, H 4.

17 procedure for multi-family problem Hypothesis testing problem with n null hypotheses grouped into m families: F 1,...,F m. Logical restrictions or connections among families F i are defined by a directed graph G where each node corresponds to exactly one family, and each directed edge represents a connection. The families F i are connected with each other to account for clinically relevant relationship among the families.

18 Graph G m nodes (one node for each family) w i 0 - family/node weights with w i 1, i g ij 0 - connection/edge weights with g ij 1. j

19 Example of a three-family graph w 1 F 1 g 21 g 13 g 12 g 31 w 2 g w 3 23 F 2 F 3 g 32

20 Overview At each step of the procedure, families are tested by component procedures. As long as the number of rejected hypotheses increases, the method allows to iterate retesting of the families with increasingly more powerful component procedures. If no additional null hypotheses are rejected at a step, the algorithm stops

21 Strong control of type I error rate Proposition The superchain procedure controls overall type I error rate at level α. Shown by constructing dominating closed testing procedure (mixture procedure) where each intersection is tested at an error rate at most α. Every null hypothesis that is rejected by the superchain procedure is also rejected by the corresponding mixture procedure.

22 Bretz, F., Maurer, W., Brannath, W., Posch, M. (2009). A graphical approach to sequentially rejective multiple test procedure. Statistics in Medicine. 28, , A., Tamhane, A.C., Wiens, B. (2008). General multistage gatekeeping procedures. Biometrical Journal. 50, , A.,, G., Tamhane, A.C. (2011). Multistage and mixture parallel gatekeeping procedures in clinical trials. Journal of Biopharmaceutical Statistics. Volume 21, Issie 4,

MULTISTAGE AND MIXTURE PARALLEL GATEKEEPING PROCEDURES IN CLINICAL TRIALS

MULTISTAGE AND MIXTURE PARALLEL GATEKEEPING PROCEDURES IN CLINICAL TRIALS Journal of Biopharmaceutical Statistics, 21: 726 747, 2011 Copyright Taylor & Francis Group, LLC ISSN: 1054-3406 print/1520-5711 online DOI: 10.1080/10543406.2011.551333 MULTISTAGE AND MIXTURE PARALLEL

More information

Bonferroni - based gatekeeping procedure with retesting option

Bonferroni - based gatekeeping procedure with retesting option Bonferroni - based gatekeeping procedure with retesting option Zhiying Qiu Biostatistics and Programming, Sanofi Bridgewater, NJ 08807, U.S.A. Wenge Guo Department of Mathematical Sciences New Jersey Institute

More information

Adaptive, graph based multiple testing procedures and a uniform improvement of Bonferroni type tests.

Adaptive, graph based multiple testing procedures and a uniform improvement of Bonferroni type tests. 1/35 Adaptive, graph based multiple testing procedures and a uniform improvement of Bonferroni type tests. Martin Posch Center for Medical Statistics, Informatics and Intelligent Systems Medical University

More information

A Mixture Gatekeeping Procedure Based on the Hommel Test for Clinical Trial Applications

A Mixture Gatekeeping Procedure Based on the Hommel Test for Clinical Trial Applications A Mixture Gatekeeping Procedure Based on the Hommel Test for Clinical Trial Applications Thomas Brechenmacher (Dainippon Sumitomo Pharma Co., Ltd.) Jane Xu (Sunovion Pharmaceuticals Inc.) Alex Dmitrienko

More information

Testing a secondary endpoint after a group sequential test. Chris Jennison. 9th Annual Adaptive Designs in Clinical Trials

Testing a secondary endpoint after a group sequential test. Chris Jennison. 9th Annual Adaptive Designs in Clinical Trials Testing a secondary endpoint after a group sequential test Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj 9th Annual Adaptive Designs in

More information

Mixtures of multiple testing procedures for gatekeeping applications in clinical trials

Mixtures of multiple testing procedures for gatekeeping applications in clinical trials Research Article Received 29 January 2010, Accepted 26 May 2010 Published online 18 April 2011 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/sim.4008 Mixtures of multiple testing procedures

More information

A note on tree gatekeeping procedures in clinical trials

A note on tree gatekeeping procedures in clinical trials STATISTICS IN MEDICINE Statist. Med. 2008; 06:1 6 [Version: 2002/09/18 v1.11] A note on tree gatekeeping procedures in clinical trials Alex Dmitrienko 1, Ajit C. Tamhane 2, Lingyun Liu 2, Brian L. Wiens

More information

On Generalized Fixed Sequence Procedures for Controlling the FWER

On Generalized Fixed Sequence Procedures for Controlling the FWER Research Article Received XXXX (www.interscience.wiley.com) DOI: 10.1002/sim.0000 On Generalized Fixed Sequence Procedures for Controlling the FWER Zhiying Qiu, a Wenge Guo b and Gavin Lynch c Testing

More information

Adaptive Dunnett Tests for Treatment Selection

Adaptive Dunnett Tests for Treatment Selection s for Treatment Selection Franz König 1 Werner Brannath 1 Frank Bretz 2 Martin Posch 1 1 Section of Medical Statistics Medical University of Vienna 2 Novartis Pharma AG Basel Workshop Adaptive Designs

More information

Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim

Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim Frank Bretz Statistical Methodology, Novartis Joint work with Martin Posch (Medical University

More information

Group sequential designs for Clinical Trials with multiple treatment arms

Group sequential designs for Clinical Trials with multiple treatment arms Group sequential designs for Clinical Trials with multiple treatment arms Susanne Urach, Martin Posch Cologne, June 26, 2015 This project has received funding from the European Union s Seventh Framework

More information

Control of Directional Errors in Fixed Sequence Multiple Testing

Control of Directional Errors in Fixed Sequence Multiple Testing Control of Directional Errors in Fixed Sequence Multiple Testing Anjana Grandhi Department of Mathematical Sciences New Jersey Institute of Technology Newark, NJ 07102-1982 Wenge Guo Department of Mathematical

More information

The Design of Group Sequential Clinical Trials that Test Multiple Endpoints

The Design of Group Sequential Clinical Trials that Test Multiple Endpoints The Design of Group Sequential Clinical Trials that Test Multiple Endpoints Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj Bruce Turnbull

More information

Estimation in Flexible Adaptive Designs

Estimation in Flexible Adaptive Designs Estimation in Flexible Adaptive Designs Werner Brannath Section of Medical Statistics Core Unit for Medical Statistics and Informatics Medical University of Vienna BBS and EFSPI Scientific Seminar on Adaptive

More information

Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni based closed tests

Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni based closed tests Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni based closed tests K. Strassburger 1, F. Bretz 2 1 Institute of Biometrics & Epidemiology German Diabetes Center,

More information

A Gatekeeping Test on a Primary and a Secondary Endpoint in a Group Sequential Design with Multiple Interim Looks

A Gatekeeping Test on a Primary and a Secondary Endpoint in a Group Sequential Design with Multiple Interim Looks A Gatekeeping Test in a Group Sequential Design 1 A Gatekeeping Test on a Primary and a Secondary Endpoint in a Group Sequential Design with Multiple Interim Looks Ajit C. Tamhane Department of Industrial

More information

Family-wise Error Rate Control in QTL Mapping and Gene Ontology Graphs

Family-wise Error Rate Control in QTL Mapping and Gene Ontology Graphs Family-wise Error Rate Control in QTL Mapping and Gene Ontology Graphs with Remarks on Family Selection Dissertation Defense April 5, 204 Contents Dissertation Defense Introduction 2 FWER Control within

More information

Alpha-recycling for the analyses of primary and secondary endpoints of. clinical trials

Alpha-recycling for the analyses of primary and secondary endpoints of. clinical trials Alpharecycling for the analyses of primary and secondary endpoints of Presenters: clinical trials Mohammad Huque, Ph.D. FDA/CDER/OTS/ Office of Biostatistics Sirisha Mushti, Ph.D. Division of Biometrics

More information

Statistica Sinica Preprint No: SS R1

Statistica Sinica Preprint No: SS R1 Statistica Sinica Preprint No: SS-2017-0072.R1 Title Control of Directional Errors in Fixed Sequence Multiple Testing Manuscript ID SS-2017-0072.R1 URL http://www.stat.sinica.edu.tw/statistica/ DOI 10.5705/ss.202017.0072

More information

An Alpha-Exhaustive Multiple Testing Procedure

An Alpha-Exhaustive Multiple Testing Procedure Current Research in Biostatistics Original Research Paper An Alpha-Exhaustive Multiple Testing Procedure, Mar Chang, Xuan Deng and John Balser Boston University, Boston MA, USA Veristat, Southborough MA,

More information

Stepwise Gatekeeping Procedures in Clinical Trial Applications

Stepwise Gatekeeping Procedures in Clinical Trial Applications 984 Biometrical Journal 48 (2006) 6, 984 991 DOI: 10.1002/bimj.200610274 Stepwise Gatekeeping Procedures in Clinical Trial Applications Alex Dmitrienko *,1, Ajit C. Tamhane 2, Xin Wang 2, and Xun Chen

More information

Multiple Testing in Group Sequential Clinical Trials

Multiple Testing in Group Sequential Clinical Trials Multiple Testing in Group Sequential Clinical Trials Tian Zhao Supervisor: Michael Baron Department of Mathematical Sciences University of Texas at Dallas txz122@utdallas.edu 7/2/213 1 Sequential statistics

More information

On weighted Hochberg procedures

On weighted Hochberg procedures Biometrika (2008), 95, 2,pp. 279 294 C 2008 Biometrika Trust Printed in Great Britain doi: 10.1093/biomet/asn018 On weighted Hochberg procedures BY AJIT C. TAMHANE Department of Industrial Engineering

More information

Multiple Testing. Anjana Grandhi. BARDS, Merck Research Laboratories. Rahway, NJ Wenge Guo. Department of Mathematical Sciences

Multiple Testing. Anjana Grandhi. BARDS, Merck Research Laboratories. Rahway, NJ Wenge Guo. Department of Mathematical Sciences Control of Directional Errors in Fixed Sequence arxiv:1602.02345v2 [math.st] 18 Mar 2017 Multiple Testing Anjana Grandhi BARDS, Merck Research Laboratories Rahway, NJ 07065 Wenge Guo Department of Mathematical

More information

Finding Critical Values with Prefixed Early. Stopping Boundaries and Controlled Type I. Error for A Two-Stage Adaptive Design

Finding Critical Values with Prefixed Early. Stopping Boundaries and Controlled Type I. Error for A Two-Stage Adaptive Design Finding Critical Values with Prefixed Early Stopping Boundaries and Controlled Type I Error for A Two-Stage Adaptive Design Jingjing Chen 1, Sanat K. Sarkar 2, and Frank Bretz 3 September 27, 2009 1 ClinForce-GSK

More information

Adaptive Treatment Selection with Survival Endpoints

Adaptive Treatment Selection with Survival Endpoints Adaptive Treatment Selection with Survival Endpoints Gernot Wassmer Institut für Medizinische Statisti, Informati und Epidemiologie Universität zu Köln Joint wor with Marus Roters, Omnicare Clinical Research,

More information

Hochberg Multiple Test Procedure Under Negative Dependence

Hochberg Multiple Test Procedure Under Negative Dependence Hochberg Multiple Test Procedure Under Negative Dependence Ajit C. Tamhane Northwestern University Joint work with Jiangtao Gou (Northwestern University) IMPACT Symposium, Cary (NC), November 20, 2014

More information

Familywise Error Rate Controlling Procedures for Discrete Data

Familywise Error Rate Controlling Procedures for Discrete Data Familywise Error Rate Controlling Procedures for Discrete Data arxiv:1711.08147v1 [stat.me] 22 Nov 2017 Yalin Zhu Center for Mathematical Sciences, Merck & Co., Inc., West Point, PA, U.S.A. Wenge Guo Department

More information

Alpha-Investing. Sequential Control of Expected False Discoveries

Alpha-Investing. Sequential Control of Expected False Discoveries Alpha-Investing Sequential Control of Expected False Discoveries Dean Foster Bob Stine Department of Statistics Wharton School of the University of Pennsylvania www-stat.wharton.upenn.edu/ stine Joint

More information

Multiple Testing of General Contrasts: Truncated Closure and the Extended Shaffer-Royen Method

Multiple Testing of General Contrasts: Truncated Closure and the Extended Shaffer-Royen Method Multiple Testing of General Contrasts: Truncated Closure and the Extended Shaffer-Royen Method Peter H. Westfall, Texas Tech University Randall D. Tobias, SAS Institute Pairwise Comparisons ANOVA, g =10groups,

More information

Adaptive clinical trials with subgroup selection

Adaptive clinical trials with subgroup selection Adaptive clinical trials with subgroup selection Nigel Stallard 1, Tim Friede 2, Nick Parsons 1 1 Warwick Medical School, University of Warwick, Coventry, UK 2 University Medical Center Göttingen, Göttingen,

More information

Adaptive Designs: Why, How and When?

Adaptive Designs: Why, How and When? Adaptive Designs: Why, How and When? Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj ISBS Conference Shanghai, July 2008 1 Adaptive designs:

More information

A class of improved hybrid Hochberg Hommel type step-up multiple test procedures

A class of improved hybrid Hochberg Hommel type step-up multiple test procedures Biometrika (2014), 101,4,pp. 899 911 doi: 10.1093/biomet/asu032 Printed in Great Britain Advance Access publication 24 October 2014 A class of improved hybrid Hochberg Hommel type step-up multiple test

More information

Testing a Primary and a Secondary Endpoint in a Confirmatory Group Sequential Clinical Trial

Testing a Primary and a Secondary Endpoint in a Confirmatory Group Sequential Clinical Trial Testing a Primary and a Secondary Endpoint in a Confirmatory Group Sequential Clinical Trial ExL Pharma Workshop 2010 Rockville, MD Cyrus R. Mehta President, Cytel Corporation January 26, 2010 email: mehta@cytel.com

More information

Adaptive designs beyond p-value combination methods. Ekkehard Glimm, Novartis Pharma EAST user group meeting Basel, 31 May 2013

Adaptive designs beyond p-value combination methods. Ekkehard Glimm, Novartis Pharma EAST user group meeting Basel, 31 May 2013 Adaptive designs beyond p-value combination methods Ekkehard Glimm, Novartis Pharma EAST user group meeting Basel, 31 May 2013 Outline Introduction Combination-p-value method and conditional error function

More information

Multistage Tests of Multiple Hypotheses

Multistage Tests of Multiple Hypotheses Communications in Statistics Theory and Methods, 39: 1597 167, 21 Copyright Taylor & Francis Group, LLC ISSN: 361-926 print/1532-415x online DOI: 1.18/3619282592852 Multistage Tests of Multiple Hypotheses

More information

Lecture 6 April

Lecture 6 April Stats 300C: Theory of Statistics Spring 2017 Lecture 6 April 14 2017 Prof. Emmanuel Candes Scribe: S. Wager, E. Candes 1 Outline Agenda: From global testing to multiple testing 1. Testing the global null

More information

Adaptive Extensions of a Two-Stage Group Sequential Procedure for Testing a Primary and a Secondary Endpoint (II): Sample Size Re-estimation

Adaptive Extensions of a Two-Stage Group Sequential Procedure for Testing a Primary and a Secondary Endpoint (II): Sample Size Re-estimation Research Article Received XXXX (www.interscience.wiley.com) DOI: 10.100/sim.0000 Adaptive Extensions of a Two-Stage Group Sequential Procedure for Testing a Primary and a Secondary Endpoint (II): Sample

More information

Group Sequential Trial with a Biomarker Subpopulation

Group Sequential Trial with a Biomarker Subpopulation Group Sequential Trial with a Biomarker Subpopulation Ting-Yu (Jeff) Chen, Jing Zhao, Linda Sun and Keaven Anderson ASA Biopharm Workshop, Sep 13th. 2018 1 Outline Motivation: Phase III PD-L1/PD-1 Monotherapy

More information

The International Journal of Biostatistics

The International Journal of Biostatistics The International Journal of Biostatistics Volume 7, Issue 1 2011 Article 12 Consonance and the Closure Method in Multiple Testing Joseph P. Romano, Stanford University Azeem Shaikh, University of Chicago

More information

Confidence intervals and point estimates for adaptive group sequential trials

Confidence intervals and point estimates for adaptive group sequential trials Confidence intervals and point estimates for adaptive group sequential trials Lingyun Liu, Ph.D. Cytel Inc. August 02, 2011 Miami, FL Lingyun Liu (Cytel Inc.) JSM August 02, 2011 Miami, FL 1 / 19 Acknowledgement

More information

Comparing Adaptive Designs and the. Classical Group Sequential Approach. to Clinical Trial Design

Comparing Adaptive Designs and the. Classical Group Sequential Approach. to Clinical Trial Design Comparing Adaptive Designs and the Classical Group Sequential Approach to Clinical Trial Design Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj

More information

Sample Size and Power I: Binary Outcomes. James Ware, PhD Harvard School of Public Health Boston, MA

Sample Size and Power I: Binary Outcomes. James Ware, PhD Harvard School of Public Health Boston, MA Sample Size and Power I: Binary Outcomes James Ware, PhD Harvard School of Public Health Boston, MA Sample Size and Power Principles: Sample size calculations are an essential part of study design Consider

More information

arxiv: v1 [math.st] 14 Nov 2012

arxiv: v1 [math.st] 14 Nov 2012 The Annals of Statistics 2010, Vol. 38, No. 6, 3782 3810 DOI: 10.1214/10-AOS829 c Institute of Mathematical Statistics, 2010 arxiv:1211.3313v1 [math.st] 14 Nov 2012 THE SEQUENTIAL REJECTION PRINCIPLE OF

More information

Power assessment in group sequential design with multiple biomarker subgroups for multiplicity problem

Power assessment in group sequential design with multiple biomarker subgroups for multiplicity problem Power assessment in group sequential design with multiple biomarker subgroups for multiplicity problem Lei Yang, Ph.D. Statistical Scientist, Roche (China) Holding Ltd. Aug 30 th 2018, Shanghai Jiao Tong

More information

Sequential/Adaptive Benchmarking

Sequential/Adaptive Benchmarking Sequential/Adaptive Benchmarking Manuel J. A. Eugster Institut für Statistik Ludwig-Maximiliams-Universität München Validation in Statistics and Machine Learning, 2010 1 / 22 Benchmark experiments Data

More information

Philippe Delorme a, Pierre Lafaye de Micheaux a,

Philippe Delorme a, Pierre Lafaye de Micheaux a, Package SSDDA : Sample Size Determination and Data Analysis in the context of continuous co-primary endpoints in clinical trials. Philippe Delorme a, Pierre Lafaye de Micheaux a, Benoît Liquet c,d and

More information

Simultaneous identifications of the minimum effective dose in each of several groups

Simultaneous identifications of the minimum effective dose in each of several groups Journal of Statistical Computation and Simulation Vol. 77, No. 2, February 2007, 149 161 Simultaneous identifications of the minimum effective dose in each of several groups SHOW-LI JAN*, YUH-ING CHEN

More information

Structured testing of 2 2 factorial effects: an analytic plan requiring fewer observations

Structured testing of 2 2 factorial effects: an analytic plan requiring fewer observations Structured testing of 2 2 factorial effects: an analytic plan requiring fewer observations Dylan S. Small, Kevin G. Volpp, Paul R. Rosenbaum Department of Statistics and Department of Medicine University

More information

CHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity

CHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity CHL 5225H Advanced Statistical Methods for Clinical Trials: Multiplicity Prof. Kevin E. Thorpe Dept. of Public Health Sciences University of Toronto Objectives 1. Be able to distinguish among the various

More information

Analysis of Multiple Endpoints in Clinical Trials

Analysis of Multiple Endpoints in Clinical Trials Chapter 4 Analysis of Multiple Endpoints in Clinical Trials Ajit C. Tamhane Northwestern University Alex Dmitrienko Eli Lilly and Company 4.1 Introduction Most human diseases are characterized by multidimensional

More information

Optimal exact tests for multiple binary endpoints

Optimal exact tests for multiple binary endpoints Optimal exact tests for multiple binary endpoints Robin Ristl 1, Dong Xi, Ekkehard Glimm 3,4, Martin Posch 1 December 3, 16 arxiv:161.7561v1 [stat.me] Dec 16 Abstract In confirmatory clinical trials with

More information

A Brief Introduction to Intersection-Union Tests. Jimmy Akira Doi. North Carolina State University Department of Statistics

A Brief Introduction to Intersection-Union Tests. Jimmy Akira Doi. North Carolina State University Department of Statistics Introduction A Brief Introduction to Intersection-Union Tests Often, the quality of a product is determined by several parameters. The product is determined to be acceptable if each of the parameters meets

More information

BLINDED EVALUATIONS OF EFFECT SIZES IN CLINICAL TRIALS: COMPARISONS BETWEEN BAYESIAN AND EM ANALYSES

BLINDED EVALUATIONS OF EFFECT SIZES IN CLINICAL TRIALS: COMPARISONS BETWEEN BAYESIAN AND EM ANALYSES BLINDED EVALUATIONS OF EFFECT SIZES IN CLINICAL TRIALS: COMPARISONS BETWEEN BAYESIAN AND EM ANALYSES IBRAHIM TURKOZ, PhD Janssen Research & Development LLC, NJ BASS XX Nov, 013 BASS XX 1 Outline Introduction

More information

High-Throughput Sequencing Course. Introduction. Introduction. Multiple Testing. Biostatistics and Bioinformatics. Summer 2018

High-Throughput Sequencing Course. Introduction. Introduction. Multiple Testing. Biostatistics and Bioinformatics. Summer 2018 High-Throughput Sequencing Course Multiple Testing Biostatistics and Bioinformatics Summer 2018 Introduction You have previously considered the significance of a single gene Introduction You have previously

More information

Type-II Generalized Family-Wise Error Rate Formulas with Application to Sample Size Determination

Type-II Generalized Family-Wise Error Rate Formulas with Application to Sample Size Determination Type-II Generalized Family-Wise Error Rate Formulas with Application to Sample Size Determination Benoit Liquet 1,2, Pierre Lafaye de Micheaux 3 and Jérémie Riou 4 1 University de Pau et Pays de l Adour,

More information

This paper has been submitted for consideration for publication in Biometrics

This paper has been submitted for consideration for publication in Biometrics BIOMETRICS, 1 10 Supplementary material for Control with Pseudo-Gatekeeping Based on a Possibly Data Driven er of the Hypotheses A. Farcomeni Department of Public Health and Infectious Diseases Sapienza

More information

Multiple Testing. Hoang Tran. Department of Statistics, Florida State University

Multiple Testing. Hoang Tran. Department of Statistics, Florida State University Multiple Testing Hoang Tran Department of Statistics, Florida State University Large-Scale Testing Examples: Microarray data: testing differences in gene expression between two traits/conditions Microbiome

More information

Step-down FDR Procedures for Large Numbers of Hypotheses

Step-down FDR Procedures for Large Numbers of Hypotheses Step-down FDR Procedures for Large Numbers of Hypotheses Paul N. Somerville University of Central Florida Abstract. Somerville (2004b) developed FDR step-down procedures which were particularly appropriate

More information

ROI ANALYSIS OF PHARMAFMRI DATA:

ROI ANALYSIS OF PHARMAFMRI DATA: ROI ANALYSIS OF PHARMAFMRI DATA: AN ADAPTIVE APPROACH FOR GLOBAL TESTING Giorgos Minas, John A.D. Aston, Thomas E. Nichols and Nigel Stallard Department of Statistics and Warwick Centre of Analytical Sciences,

More information

Closure properties of classes of multiple testing procedures

Closure properties of classes of multiple testing procedures AStA Adv Stat Anal (2018) 102:167 178 https://doi.org/10.1007/s10182-017-0297-0 ORIGINAL PAPER Closure properties of classes of multiple testing procedures Georg Hahn 1 Received: 28 June 2016 / Accepted:

More information

Consonance and the Closure Method in Multiple Testing. Institute for Empirical Research in Economics University of Zurich

Consonance and the Closure Method in Multiple Testing. Institute for Empirical Research in Economics University of Zurich Institute for Empirical Research in Economics University of Zurich Working Paper Series ISSN 1424-0459 Working Paper No. 446 Consonance and the Closure Method in Multiple Testing Joseph P. Romano, Azeem

More information

Applying the Benjamini Hochberg procedure to a set of generalized p-values

Applying the Benjamini Hochberg procedure to a set of generalized p-values U.U.D.M. Report 20:22 Applying the Benjamini Hochberg procedure to a set of generalized p-values Fredrik Jonsson Department of Mathematics Uppsala University Applying the Benjamini Hochberg procedure

More information

2015 Duke-Industry Statistics Symposium. Sample Size Determination for a Three-arm Equivalence Trial of Poisson and Negative Binomial Data

2015 Duke-Industry Statistics Symposium. Sample Size Determination for a Three-arm Equivalence Trial of Poisson and Negative Binomial Data 2015 Duke-Industry Statistics Symposium Sample Size Determination for a Three-arm Equivalence Trial of Poisson and Negative Binomial Data Victoria Chang Senior Statistician Biometrics and Data Management

More information

Testing hypotheses in order

Testing hypotheses in order Biometrika (2008), 95, 1,pp. 248 252 C 2008 Biometrika Trust Printed in Great Britain doi: 10.1093/biomet/asm085 Advance Access publication 24 January 2008 Testing hypotheses in order BY PAUL R. ROSENBAUM

More information

PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH

PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH The First Step: SAMPLE SIZE DETERMINATION THE ULTIMATE GOAL The most important, ultimate step of any of clinical research is to do draw inferences;

More information

Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection

Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection Research Article Statistics Received XXXX (www.interscience.wiley.com) DOI: 10.1002/sim.0000 Designing multi-arm multi-stage clinical trials using a risk-benefit criterion for treatment selection Thomas

More information

gmcp - an R package for a graphical approach to weighted multiple test procedures

gmcp - an R package for a graphical approach to weighted multiple test procedures gmcp - an R package for a graphical approach to weighted multiple test procedures Kornelius Rohmeyer August 8, 6 Contents Introduction. Installation............................................... Basic

More information

Controlling the False Discovery Rate in Two-Stage. Combination Tests for Multiple Endpoints

Controlling the False Discovery Rate in Two-Stage. Combination Tests for Multiple Endpoints Controlling the False Discovery Rate in Two-Stage Combination Tests for Multiple ndpoints Sanat K. Sarkar, Jingjing Chen and Wenge Guo May 29, 2011 Sanat K. Sarkar is Professor and Senior Research Fellow,

More information

UNIFORMLY MOST POWERFUL TESTS FOR SIMULTANEOUSLY DETECTING A TREATMENT EFFECT IN THE OVERALL POPULATION AND AT LEAST ONE SUBPOPULATION

UNIFORMLY MOST POWERFUL TESTS FOR SIMULTANEOUSLY DETECTING A TREATMENT EFFECT IN THE OVERALL POPULATION AND AT LEAST ONE SUBPOPULATION UNIFORMLY MOST POWERFUL TESTS FOR SIMULTANEOUSLY DETECTING A TREATMENT EFFECT IN THE OVERALL POPULATION AND AT LEAST ONE SUBPOPULATION BY MICHAEL ROSENBLUM Department of Biostatistics, Johns Hopkins Bloomberg

More information

Optimizing trial designs for targeted therapies - A decision theoretic approach comparing sponsor and public health perspectives

Optimizing trial designs for targeted therapies - A decision theoretic approach comparing sponsor and public health perspectives Optimizing trial designs for targeted therapies - A decision theoretic approach comparing sponsor and public health perspectives Thomas Ondra Sebastian Jobjörnsson Section for Medical Statistics, Medical

More information

Multiple Endpoints: A Review and New. Developments. Ajit C. Tamhane. (Joint work with Brent R. Logan) Department of IE/MS and Statistics

Multiple Endpoints: A Review and New. Developments. Ajit C. Tamhane. (Joint work with Brent R. Logan) Department of IE/MS and Statistics 1 Multiple Endpoints: A Review and New Developments Ajit C. Tamhane (Joint work with Brent R. Logan) Department of IE/MS and Statistics Northwestern University Evanston, IL 60208 ajit@iems.northwestern.edu

More information

University of California, Berkeley

University of California, Berkeley University of California, Berkeley U.C. Berkeley Division of Biostatistics Working Paper Series Year 2010 Paper 267 Optimizing Randomized Trial Designs to Distinguish which Subpopulations Benefit from

More information

A NEW APPROACH FOR LARGE SCALE MULTIPLE TESTING WITH APPLICATION TO FDR CONTROL FOR GRAPHICALLY STRUCTURED HYPOTHESES

A NEW APPROACH FOR LARGE SCALE MULTIPLE TESTING WITH APPLICATION TO FDR CONTROL FOR GRAPHICALLY STRUCTURED HYPOTHESES A NEW APPROACH FOR LARGE SCALE MULTIPLE TESTING WITH APPLICATION TO FDR CONTROL FOR GRAPHICALLY STRUCTURED HYPOTHESES By Wenge Guo Gavin Lynch Joseph P. Romano Technical Report No. 2018-06 September 2018

More information

Sleep data, two drugs Ch13.xls

Sleep data, two drugs Ch13.xls Model Based Statistics in Biology. Part IV. The General Linear Mixed Model.. Chapter 13.3 Fixed*Random Effects (Paired t-test) ReCap. Part I (Chapters 1,2,3,4), Part II (Ch 5, 6, 7) ReCap Part III (Ch

More information

Interim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming. and Optimal Stopping

Interim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming. and Optimal Stopping Interim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj

More information

Pubh 8482: Sequential Analysis

Pubh 8482: Sequential Analysis Pubh 8482: Sequential Analysis Joseph S. Koopmeiners Division of Biostatistics University of Minnesota Week 10 Class Summary Last time... We began our discussion of adaptive clinical trials Specifically,

More information

Sequential tests controlling generalized familywise error rates

Sequential tests controlling generalized familywise error rates Sequential tests controlling generalized familywise error rates Shyamal K. De a, Michael Baron b,c, a School of Mathematical Sciences, National Institute of Science Education and Research, Bhubaneswar,

More information

Technical Manual. 1 Introduction. 1.1 Version. 1.2 Developer

Technical Manual. 1 Introduction. 1.1 Version. 1.2 Developer Technical Manual 1 Introduction 1 2 TraditionalSampleSize module: Analytical calculations in fixed-sample trials 3 3 TraditionalSimulations module: Simulation-based calculations in fixed-sample trials

More information

A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials

A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials Biometria (24), 91, 3, pp. 715 727 24 Biometria Trust Printed in Great Britain A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials BY AJIT C. TAMHANE Department

More information

MULTIPLE TESTING TO ESTABLISH SUPERIORITY/EQUIVALENCE OF A NEW TREATMENT COMPARED WITH k STANDARD TREATMENTS

MULTIPLE TESTING TO ESTABLISH SUPERIORITY/EQUIVALENCE OF A NEW TREATMENT COMPARED WITH k STANDARD TREATMENTS STATISTICS IN MEDICINE, VOL 16, 2489 2506 (1997) MULTIPLE TESTING TO ESTABLISH SUPERIORITY/EQUIVALENCE OF A NEW TREATMENT COMPARED WITH k STANDARD TREATMENTS CHARLES W DUNNETT* AND AJIT C TAMHANE Department

More information

Tests about a population mean

Tests about a population mean October 2 nd, 2017 Overview Week 1 Week 2 Week 4 Week 7 Week 10 Week 12 Chapter 1: Descriptive statistics Chapter 6: Statistics and Sampling Distributions Chapter 7: Point Estimation Chapter 8: Confidence

More information

Statistical Applications in Genetics and Molecular Biology

Statistical Applications in Genetics and Molecular Biology Statistical Applications in Genetics and Molecular Biology Volume 5, Issue 1 2006 Article 28 A Two-Step Multiple Comparison Procedure for a Large Number of Tests and Multiple Treatments Hongmei Jiang Rebecca

More information

Two-Phase, Three-Stage Adaptive Designs in Clinical Trials

Two-Phase, Three-Stage Adaptive Designs in Clinical Trials Japanese Journal of Biometrics Vol. 35, No. 2, 69 93 (2014) Preliminary Report Two-Phase, Three-Stage Adaptive Designs in Clinical Trials Hiroyuki Uesaka 1, Toshihiko Morikawa 2 and Akiko Kada 3 1 The

More information

Summary and discussion of: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

Summary and discussion of: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Summary and discussion of: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing Statistics Journal Club, 36-825 Beau Dabbs and Philipp Burckhardt 9-19-2014 1 Paper

More information

6 Sample Size Calculations

6 Sample Size Calculations 6 Sample Size Calculations A major responsibility of a statistician: sample size calculation. Hypothesis Testing: compare treatment 1 (new treatment) to treatment 2 (standard treatment); Assume continuous

More information

ADAPTIVE SEAMLESS DESIGNS: SELECTION AND PROSPECTIVE TESTING OF HYPOTHESES

ADAPTIVE SEAMLESS DESIGNS: SELECTION AND PROSPECTIVE TESTING OF HYPOTHESES ADAPTIVE SEAMLESS DESIGNS: SELECTION AND PROSPECTIVE TESTING OF HYPOTHESES Christopher Jennison Department of Mathematical Sciences, University of Bath, Bath BA2 7AY, U. K. email: cj@maths.bath.ac.uk and

More information

Group Sequential Designs: Theory, Computation and Optimisation

Group Sequential Designs: Theory, Computation and Optimisation Group Sequential Designs: Theory, Computation and Optimisation Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj 8th International Conference

More information

IEOR165 Discussion Week 12

IEOR165 Discussion Week 12 IEOR165 Discussion Week 12 Sheng Liu University of California, Berkeley Apr 15, 2016 Outline 1 Type I errors & Type II errors 2 Multiple Testing 3 ANOVA IEOR165 Discussion Sheng Liu 2 Type I errors & Type

More information

Two-stage k-sample designs for the ordered alternative problem

Two-stage k-sample designs for the ordered alternative problem Two-stage k-sample designs for the ordered alternative problem Guogen Shan, Alan D. Hutson, and Gregory E. Wilding Department of Biostatistics,University at Buffalo, Buffalo, NY 14214, USA July 18, 2011

More information

Looking at the Other Side of Bonferroni

Looking at the Other Side of Bonferroni Department of Biostatistics University of Washington 24 May 2012 Multiple Testing: Control the Type I Error Rate When analyzing genetic data, one will commonly perform over 1 million (and growing) hypothesis

More information

Mathematical statistics

Mathematical statistics October 20 th, 2018 Lecture 17: Tests of Hypotheses Overview Week 1 Week 2 Week 4 Week 7 Week 10 Week 14 Probability reviews Chapter 6: Statistics and Sampling Distributions Chapter 7: Point Estimation

More information

discovery rate control

discovery rate control Optimal design for high-throughput screening via false discovery rate control arxiv:1707.03462v1 [stat.ap] 11 Jul 2017 Tao Feng 1, Pallavi Basu 2, Wenguang Sun 3, Hsun Teresa Ku 4, Wendy J. Mack 1 Abstract

More information

On Procedures Controlling the FDR for Testing Hierarchically Ordered Hypotheses

On Procedures Controlling the FDR for Testing Hierarchically Ordered Hypotheses On Procedures Controlling the FDR for Testing Hierarchically Ordered Hypotheses Gavin Lynch Catchpoint Systems, Inc., 228 Park Ave S 28080 New York, NY 10003, U.S.A. Wenge Guo Department of Mathematical

More information

Multiple testing: Intro & FWER 1

Multiple testing: Intro & FWER 1 Multiple testing: Intro & FWER 1 Mark van de Wiel mark.vdwiel@vumc.nl Dep of Epidemiology & Biostatistics,VUmc, Amsterdam Dep of Mathematics, VU 1 Some slides courtesy of Jelle Goeman 1 Practical notes

More information

arxiv: v2 [stat.me] 6 Sep 2013

arxiv: v2 [stat.me] 6 Sep 2013 Sequential Tests of Multiple Hypotheses Controlling Type I and II Familywise Error Rates arxiv:1304.6309v2 [stat.me] 6 Sep 2013 Jay Bartroff and Jinlin Song Department of Mathematics, University of Southern

More information

Group-Sequential Tests for One Proportion in a Fleming Design

Group-Sequential Tests for One Proportion in a Fleming Design Chapter 126 Group-Sequential Tests for One Proportion in a Fleming Design Introduction This procedure computes power and sample size for the single-arm group-sequential (multiple-stage) designs of Fleming

More information

Control of Generalized Error Rates in Multiple Testing

Control of Generalized Error Rates in Multiple Testing Institute for Empirical Research in Economics University of Zurich Working Paper Series ISSN 1424-0459 Working Paper No. 245 Control of Generalized Error Rates in Multiple Testing Joseph P. Romano and

More information

Optimising Group Sequential Designs. Decision Theory, Dynamic Programming. and Optimal Stopping

Optimising Group Sequential Designs. Decision Theory, Dynamic Programming. and Optimal Stopping : Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj InSPiRe Conference on Methodology

More information

Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial

Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial William R. Gillespie Pharsight Corporation Cary, North Carolina, USA PAGE 2003 Verona,

More information